| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.912977 |
| 003 | CaOODSP |
| 005 | 20230907103555 |
| 006 | m o d f |
| 007 | cr cn||||||||| |
| 008 | 220630t20222022onc ob f000 0 eng d |
| 020 | |a9780660443638 |
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
| 043 | |an-cn--- |
| 086 | 1 |aHP40-314/2-2022E-PDF |
| 245 | 00|aGuidelines for reporting model-based economic evaluations of vaccination programs in Canada. |
| 250 | |aVersion 1.0 |
| 264 | 1|aOttawa, ON : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c2022. |
| 264 | 4|c©2022 |
| 300 | |a1 online resource (17 pages) |
| 336 | |atext|btxt|2rdacontent |
| 337 | |acomputer|bc|2rdamedia |
| 338 | |aonline resource|bcr|2rdacarrier |
| 500 | |aCover title. |
| 500 | |a"February 2022." |
| 500 | |a"Protecting and empowering Canadians to improve their health." |
| 500 | |aAt head of title: National Advisory Committee on Immunization (NACI). |
| 500 | |aIssued also in French under title: Lignes directrices pour la présentation des évaluations économiques des programmes de vaccination fondées sur des modèles au Canada. |
| 504 | |aIncludes bibliographical references (page 17). |
| 520 | |a"A structured reporting format for the preparation of economic evaluations ensures that studies are thoroughly presented and organized consistently to facilitate review and comparison by decision-makers"--Purpose, page 4. |
| 650 | 0|aVaccination|xEconomic aspects|zCanada|xEvaluation. |
| 650 | 0|aVaccination|zCanada|xCosts|xEvaluation. |
| 710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
| 710 | 1 |aCanada. |bNational Advisory Committee on Immunization, |eissuing body. |
| 775 | 08|tLignes directrices pour la présentation des évaluations économiques des programmes de vaccination fondées sur des modèles au Canada.|w(CaOODSP)9.912976 |
| 856 | 40|qPDF|s268 KB|uhttps://publications.gc.ca/collections/collection_2022/aspc-phac/HP40-314-2-2022-eng.pdf |
| 986 | |a220253 |